illumicell AI | $2,000,000 | (Apr 11, 2025)
Outtake | $16,500,000 | (Apr 11, 2025)
Bliss Aesthetics | $17,500,000 | (Apr 11, 2025)
Certified by Founder
Lodge
Initial Therapeutics
start up
United States
- South San Francisco, California
- 02/05/2023
- Series A
- $75,000,000
Initial Therapeutics is discovering and developing a new class of small-molecule medicines designed to halt pathogenic protein formation in the earliest stages.
Initial’s approach is unique and starkly differentiated from protein degradation and other interventions that recognize and tackle proteins only after they have been fully formed.
- Industry Biotechnology Research
- Website https://initialtx.com/
- LinkedIn https://www.linkedin.com/company/initial-therapeutics/people/
Dealstack | $5,500,000 | (Apr 11, 2025)
Limitless Travel | $8,497,620 | (Apr 11, 2025)
Okeiro (ex Predict4Health) | $11,360,400 | (Apr 11, 2025)
NoScrubs | $2,000,000 | (Apr 11, 2025)
Merida Biosciences | $121,000,000 | (Apr 10, 2025)
Rondah AI | $1,800,000 | (Apr 10, 2025)
Ryft | $7,315,294 | (Apr 10, 2025)
Remedy Scientific Inc. | $11,000,000 | (Apr 10, 2025)
Base Power Company | $200,000,000 | (Apr 10, 2025)